Omecamtiv Mecarbil in Systolic Heart Failure. Reply.
Publication
, Journal Article
Teerlink, JR; Felker, GM; McMurray, JJV
Published in: N Engl J Med
May 20, 2021
Duke Scholars
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
May 20, 2021
Volume
384
Issue
20
Start / End Page
1967 / 1968
Location
United States
Related Subject Headings
- Urea
- Stroke Volume
- Humans
- Heart Failure, Systolic
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Teerlink, J. R., Felker, G. M., & McMurray, J. J. V. (2021). Omecamtiv Mecarbil in Systolic Heart Failure. Reply. N Engl J Med, 384(20), 1967–1968. https://doi.org/10.1056/NEJMc2102893
Teerlink, John R., G Michael Felker, and John J. V. McMurray. “Omecamtiv Mecarbil in Systolic Heart Failure. Reply.” N Engl J Med 384, no. 20 (May 20, 2021): 1967–68. https://doi.org/10.1056/NEJMc2102893.
Teerlink JR, Felker GM, McMurray JJV. Omecamtiv Mecarbil in Systolic Heart Failure. Reply. N Engl J Med. 2021 May 20;384(20):1967–8.
Teerlink, John R., et al. “Omecamtiv Mecarbil in Systolic Heart Failure. Reply.” N Engl J Med, vol. 384, no. 20, May 2021, pp. 1967–68. Pubmed, doi:10.1056/NEJMc2102893.
Teerlink JR, Felker GM, McMurray JJV. Omecamtiv Mecarbil in Systolic Heart Failure. Reply. N Engl J Med. 2021 May 20;384(20):1967–1968.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
May 20, 2021
Volume
384
Issue
20
Start / End Page
1967 / 1968
Location
United States
Related Subject Headings
- Urea
- Stroke Volume
- Humans
- Heart Failure, Systolic
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences